Zaltenibart inhibits the intravascular hemolysis treated by C5 inhibitors as well as the extravascular hemolysis caused by C5 inhibitors in patients suffering from PNH while leaving intact the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback